V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200004716 | 200004716 | null | null | 03 | 2016-06-19 | 2016-06-28 | null | 02 | null | DABRAFENIB + TRAMETINIB | 101625360 |
| 200004719 | 200004719 | null | null | Palliative (P) | 2018-06-13 | 2018-06-13 | NIVOLUMAB | 02 | N | DABRAFENIB + TRAMETINIB | 100844636 |
| 200004723 | 200004723 | null | null | null | null | 2017-03-06 | IBRUTINIB | null | null | PEMBROLIZUMAB | 101621702 |
| 200004727 | 200004727 | 0 | 0 | Palliative (P) | 2019-05-11 | 2019-05-21 | NIVOLUMAB | 02 | null | BCG | 101800001 |
| 200004729 | 200004729 | null | null | Palliative (P) | 2019-01-04 | 2019-01-05 | DABRAFENIB + TRAMETINIB | 02 | null | DABRAFENIB | 101863881 |
| 200004732 | 200004732 | null | null | Adjuvant (A) | 2016-08-17 | 2016-08-30 | null | 02 | null | NIVOLUMAB | 100541759 |
| 200004733 | 200004733 | null | null | null | null | 2018-06-01 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 101373161 |
| 200004736 | 200004736 | null | null | Palliative (P) | 2017-05-21 | 2017-06-03 | Capecitabine + Oxaliplatin 14day | 02 | null | IPILIMUMAB + NIVOLUMAB | 101403387 |
| 200004740 | 200004740 | null | null | Palliative (P) | 2021-06-11 | 2021-06-11 | null | N | Y | TRIAL UNSPECIFIED | 101523945 |
| 200004747 | 200004747 | null | null | Palliative (P) | 2018-07-28 | 2018-07-28 | null | 02 | null | DABRAFENIB + TRAMETINIB | 100159557 |
| 200004748 | 200004748 | null | null | null | null | 2019-08-20 | DABRAFENIB + TRAMETINIB | null | null | IBRUTINIB | 100667086 |
| 200004760 | 200004760 | null | null | Disease modification (D) | 2018-01-01 | 2018-01-01 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100748609 |
| 200004773 | 200004773 | null | null | 03 | 2020-03-29 | 2020-04-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | PEMBROLIZUMAB | 101075022 |
| 200004781 | 200004781 | null | null | null | null | 2020-11-23 | NIVOLUMAB | null | null | PEMBROLIZUMAB | 100320011 |
| 200004788 | 200004788 | null | null | null | null | 2022-02-22 | DABRAFENIB + TRAMETINIB | null | null | DABRAFENIB + TRAMETINIB | 101272594 |
| 200004807 | 200004807 | null | null | null | null | 2019-01-02 | NIVOLUMAB | null | null | TRIAL | 100142591 |
| 200004814 | 200004814 | null | null | Palliative (P) | null | 2019-06-26 | DABRAFENIB + TRAMETINIB | 02 | null | PEMBROLIZUMAB | 101087713 |
| 200004815 | 200004815 | null | null | null | null | 2019-08-12 | IPILIMUMAB + NIVOLUMAB | null | null | PEMBROLIZUMAB | 101382721 |
| 200004820 | 200004820 | null | null | Curative (C) | null | 2015-02-24 | Docetaxel | 02 | N | DABRAFENIB + TRAMETINIB | 100930891 |
| 200004825 | 200004825 | null | null | Disease modification (D) | 2019-03-21 | 2019-04-15 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100389575 |
| 200004826 | 200004826 | null | null | Palliative (P) | 2019-10-19 | 2019-10-20 | null | 02 | N | PEMBROLIZUMAB | 100150935 |
| 200004828 | 200004828 | 1.66 | 82 | Palliative (P) | 2019-09-02 | 2019-09-05 | NIVOLUMAB | 02 | N | DABRAFENIB + TRAMETINIB | 100655165 |
| 200004838 | 200004838 | null | null | Palliative (P) | 2018-09-28 | 2018-09-28 | Ipilimumab | 02 | null | IPILIMUMAB + NIVOLUMAB | 100431198 |
| 200004842 | 200004842 | null | null | Palliative (P) | 2015-06-18 | 2015-07-02 | DABRAFENIB + TRAMETINIB | 02 | null | NIVOLUMAB | 100548939 |
| 200004847 | 200004847 | null | null | Palliative (P) | 2019-06-08 | 2019-06-28 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101348173 |
| 200004857 | 200004857 | 1.68 | 74.6 | Disease modification (D) | 2017-05-24 | 2017-05-30 | null | 02 | null | IPILIMUMAB | 101286397 |
| 200004859 | 200004859 | null | null | Palliative (P) | 2016-07-26 | 2016-07-31 | null | 02 | N | DABRAFENIB + TRAMETINIB | 100284036 |
| 200004887 | 200004887 | null | null | Adjuvant (A) | 2017-03-12 | 2017-03-21 | null | 02 | null | PEMBROLIZUMAB | 101472268 |
| 200004892 | 200004892 | null | null | Adjuvant (A) | 2018-04-03 | 2018-04-28 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101854300 |
| 200004893 | 200004893 | null | null | null | null | 2018-06-21 | DABRAFENIB + TRAMETINIB | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101551968 |
| 200004899 | 200004899 | null | null | Palliative (P) | 2018-07-28 | 2018-08-07 | null | N | N | PEMBROLIZUMAB | 101006994 |
| 200004901 | 200004901 | null | null | null | null | 2018-10-26 | null | null | null | NIVOLUMAB | 100104233 |
| 200004904 | 200004904 | null | null | Palliative (P) | 2018-11-16 | 2018-11-26 | Dacarbazine | 02 | null | PEMBROLIZUMAB | 100346836 |
| 200004905 | 200004905 | null | null | Adjuvant (A) | 2016-09-03 | 2016-09-11 | IPILIMUMAB + NIVOLUMAB | 01 | N | DABRAFENIB | 101610122 |
| 200004908 | 200004908 | null | null | Adjuvant (A) | null | 2020-02-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | NIVOLUMAB | 100554874 |
| 200004913 | 200004913 | null | null | null | null | 2018-09-07 | DABRAFENIB + TRAMETINIB | null | null | NIVOLUMAB | 101272003 |
| 200004917 | 200004917 | null | null | 03 | 2017-07-28 | 2017-07-28 | ABVD | 02 | null | DABRAFENIB + TRAMETINIB | 101224241 |
| 200004922 | 200004922 | null | null | Palliative (P) | 2013-10-20 | 2013-10-30 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101007199 |
| 200004924 | 200004924 | null | null | Adjuvant (A) | 2020-06-12 | 2020-06-12 | PEMBROLIZUMAB | 02 | null | TRIAL UNSPECIFIED | 100297220 |
| 200004925 | 200004925 | null | null | null | null | 2016-04-06 | null | null | null | DABRAFENIB + TRAMETINIB | 100287611 |
| 200004945 | 200004945 | null | null | null | null | 2018-07-18 | null | null | null | PEMBROLIZUMAB | 100693030 |
| 200004949 | 200004949 | 1.67 | 95.2 | null | null | 2016-12-03 | DABRAFENIB + TRAMETINIB | null | null | IPILIMUMAB | 100897521 |
| 200004955 | 200004955 | null | null | Neo-adjuvant (N) | 2017-01-10 | 2017-01-23 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101078859 |
| 200004962 | 200004962 | null | null | null | null | 2016-10-01 | Dacarbazine | null | null | SELPAC TRIAL | 100485261 |
| 200004965 | 200004965 | null | null | null | null | 2017-09-17 | Ipilimumab | null | null | DABRAFENIB + TRAMETINIB | 101049293 |
| 200004978 | 200004978 | null | null | Adjuvant (A) | 2018-05-01 | 2018-05-02 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101854530 |
| 200004981 | 200004981 | null | null | null | null | 2018-08-09 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101699834 |
| 200004985 | 200004985 | null | null | null | null | 2019-04-26 | INTERIM Trial | null | null | CHLORAMBUCIL | 100289629 |
| 200005004 | 200005004 | null | null | 03 | 2019-01-26 | 2019-02-06 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101101904 |
| 200005009 | 200005009 | null | null | null | null | 2018-11-18 | DABRAFENIB + TRAMETINIB | null | null | BINIMETINIB + ENCORAFENIB | 101839250 |